Compare Ascendis Pharma A/S (ASND) vs Docusign Inc (DOCU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Docusign Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Docusign Inc trades at $58.39 (market cap $11.33B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Docusign Inc nearer its low. Which is the better fit depends on your goals.
| ASND | DOCU | |
|---|---|---|
Market Cap | $16.67B | $11.33B |
Sector | Health | Technology |
52-Week High | $277.18 | $85.01 |
52-Week Low | $189.74 | $41.75 |
Enterprise Value | $17.04B | $10.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →
